AOAtsunori Oga

Atsunori Oga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Atsunori Oga has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epstein-Barr Virus in Gastric Carcinoma

    by Jun Nishikawa, Hironori Yoshiyama, Hisashi Iizasa, Yuichi Kanehiro, Munetaka Nakamura, Junichi Nishimura, Mari Saito, Takeshi Okamoto, Kouhei Sakai, Yutaka Suehiro, et al.

    The Epstein-Barr virus (EBV) is detected in about 10% of gastric carcinoma cases throughout the world. In EBV-associated gastric carcinoma, all tumor cells harbor the clonal EBV genome. Gastric carcinoma associated with EBV has distinct clinicopathological features, occurs predominately in men and in younger-aged individuals, and presents a generally diffuse histological type. Most cases of EBV-associated gastric carcinoma exhibit a histology rich in lymphocyte infiltration. The immunological reactiveness in the host may represent a relatively preferable prognosis in EBV-positive cases. This fact highlights the important role of EBV in the development of EBV-associated gastric carcinoma. We have clearly proved direct infection of human gastric epithelialcells by EBV. The infection was achieved by using a recombinant EBV. Promotion of growth by EBV infection was observed in the cells. Considerable data suggest that EBV may directly contribute to the development of EBV-associated GC. This tumor-promoting effect seems to involve multiple mechanisms, because EBV affects several host proteins and pathways that normally promote apoptosis and regulate cell proliferation.


  • Bleeding from a diverticulum of the appendix (with video)

    by Kouichi Hamabe, Munetaka Nakamura, Jun Nishikawa, Tomoki Hitosugi, Youhei Nakamura, Takeshi Iida, Miyuki Kaino, Fumie Kurokawa, Kumiko Yoshida, Masahiko Onoda, et al.

  • Open Access

    Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype

    by Masumi Yanagawa, Kenzo Ikemot, Shigeto Kawauchi, Tomoko Furuya, Shigeru Yamamoto, Masaaki Oka, Atunori Oga, Yukiko Nagashima, Kohsuke Sasaki

    Background: The St Gallen International Expert Consensus 2011 has proposed a new classification system for breast cancer. The purpose of this study was to elucidate the relationship between the breast cancer subtypes determined by the new classification system and genomic characteristics. Methods: Invasive breast cancers (n = 363) were immunohistochemically classified as follows: 111 (30.6%) as luminal A, 95 (26.2%) as luminal B (HER2 negative), 69 (19.0%) as luminal B (HER2 positive), 41 (11.3%) as HER2, and 47 (12.9%) as basal-like subtypes. Results: The high expression of Ki-67 antigen was detected in 236 tumors; no cases of luminal A subtype showed high expression of the Ki-67 antigen, but more than 85% of tumors of the other subtypes showed high expression. In addition, DNA ploidy and chromosomal instability (CIN) were assessed using imaging cytometry and FISH, respectively. In this series, 336 (92.6%) tumors consisted of 129 diploid/CIN- and 207 aneuploid/CIN + tumors. Diploid/CIN- and aneuploid/CIN+ features were detected in 64.9% and 27.9% of luminal A, 41.1% and 49.5% of luminal B (HER2-), 11.6% and 81.2% of luminal B (HER2+), 4.9% and 90.2% of HER2, and 17.0% and 76.6% of basal-like subtypes, respectively. Unlike the luminal B (HER2+), HER2 and basal-like subtypes, the luminal A and luminal B (HER2-) subtypes were heterogeneous in terms of DNA ploidy and CIN. Conclusions: It is reasonable to propose that the luminal A and luminal B (HER2-) subtypes should be further divided into two subgroups, diploid/CIN- and aneuploid/CIN+, based on their underlying genomic status.


  • Open Access

    Loss of 6q or 8p23 is associated with the total number of DNA copy number aberrations in adenoid cystic carcinoma

    by Atsunori Oga, Kenichiro Uchida, Motonao Nakao, Shigeto Kawauchi, Tomoko Furuya, Yasuyo Chochi, Kenzo Ikemoto, Takae Okada, Yoshiya Ueyama, Kohsuke Sasaki, et al.

    We analyzed 10 adenoid cystic carcinomas (ACCs) of the salivary glands by array-based comparative genomic hybridization (a-CGH) using DNA chips spotted with 4,030 bacterial artificial chromosome clones. After the data smoothing procedure was applied, a total of 88 DNA copy number aberrations (DCNAs) were detected. The frequent (≥30%) DCNAs were loss of 6q23-27 and 8p23, and gains of 6p, 6q23, 8p23 and 22q13. High-level gains were detected on 12q15, including MDM2 in two cases. These two cases showed an immunohistochemically high-level (>50%) expression of MDM2 and a low-level expression of p53 (<20%). Furthermore, the total number of DCNAs was significantly greater in ACCs with loss of 6q compared to other ACCs, and in ACCs without the loss of 8p23 compared to other ACCs, respectively. Although limitations exist, a-CGH detected several candidate chromosomal imbalances associated with accumulation of DCNAs in ACCs.


  • Loss of 3p26.3 is an independent prognostic factor in patients with oral squamous cell carcinoma

    by Kenichiro Uchida, Atsunori Oga, Motonao Nakao, Takamitsu Mano, Mariko Mihara, Shigeto Kawauchi, Tomoko Furuya, Yoshiya Ueyama, Kohsuke Sasaki

    Oral squamous cell carcinoma (OSCC) is a common malignancy worldwide and the prognosis for patients with advanced-stage OSCC is particularly poor. To identify DNA copy number aberrations and candidate genes associated with a poor or favorable outcome, we analyzed the genome profiles of OSCC tumors by array-based comparative genomic hybrid-ization (A-CGH). This technique uses DNA microarray technology to detect genomic copy number variations at a higher resolution level than chromosome-based CGH. Fifty patients with primary OSCCs were included in the study. Of these 50 patients, 37 were treated surgically and 13 were treated without surgery and had received irradiation and/or chemotherapy. All samples were analyzed by A-CGH. Gains were detected frequently (>50%) at chromosomal regions 5p15.33, 7p22.3, 8q21.1-24.3, 9q34.3, 11q13, 16p13.3 and 20q13.3. Losses were frequently detected at 3p22, 3p14 and 4q35.2. High-level gains were recurrently (>10%) detected at each of 5p15, 7p22, 7p11, 8q24, 11q13, 11q22 and 22q11. Gains of 2p25.1, 11p15, 16p13.3, 16q24.3 and 20q13.3 were inversely correlated with nodal metastasis. In 37 of the 50 OSCC patients treated with surgery, gains of 8q12.1-24.22 and losses of 3p26.2-3 were associated with disease-specific survival (p<0.01). Loss of a 0.2 Mb chromosomal region in 3p26.3 was associated with a poor prognostic outcome in the Kaplan-Meier analysis (p<0.01 by the log-rank test). Multivariate analysis revealed that loss of 3p26.3 is an independent prognostic factor (p<0.01) of OSCC. Loss of a 0.2 Mb chromosomal region in 3p26.3 including the CHL1 (cell adhesion molecule with homology to L1CAM1) gene was identified as a novel potential marker for predicting the prognosis of patients with OSCC.


  • Open Access

    DNA copy number aberrations associated with the clinicopathological features of colorectal cancers: Identification of genomic biomarkers by array-based comparative genomic hybridization

    by Kohsuke Sasaki, Motonao Nakao, Shigeto Kawauchi, Tetsuji Uchiyama, Jun Adachi, Hideaki Ito, Yasuyo Chochi, Tomoko Furuya, Atsunori Oga

    The aim of the present study was to investigate the chromosomal aberrations that are linked with the crucial clinicopathological features of colorectal cancer (CRC) and its prognosis by array-based comparative genomic hybridization (CGH). Fresh-frozen tumor tissues of 94 cases of CRC were analyzed by using bacterial artificial chromosome (BAC) CGH slides spotted with 4030 human BAC clones, which covered the whole range of the human genome at an average interval of 0.83 mega base pairs. DNA copy number aberrations (DCNAs) were identified in association with clinicopathological features: a gain of 8q24.3 and losses of 9q33.1 and 20p12.2 were associated with lymph node metastasis, gain of 8q24.3 and loss of 9q33.1 with disease stage, gain of 8q21.11 and loss of 10q21.3 with lymphovascular invasion and losses of 3p25.1, 10p15.3, 12q15 and 17p13.1 for venous invasion. These aberrations can be regarded as genomic biomarkers to predict the clinical outcome of patients with CRC, and are expected to serve to individualize the treatment of CRC patients.


  • Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports

    by Kenichiro Uchida, Atsunori Oga, Takamitsu Mano, Hitoshi Nagatsuka, Yoshiya Ueyama, Kohsuke Sasaki


  • Open Access

    The development of a mini-array for estimating the disease state of gastric adenocarcinoma by array CGH

    by Tomoko Furuya, Tetsuji Uchiyama, Atsushi Adachi, Takae Okada, Motonao Nakao, Atsunori Oga, Song-Ju Yang, Shigeto Kawauchi, Kohsuke Sasaki

    Background: The treatment strategy usually depends on the disease state in the individual patient. However, it is difficult to estimate the disease state before treatment in many patients. The purpose of this study was to develop a BAC (bacterial artificial chromosome) mini-array allowing for the estimation of node metastasis, liver metastasis, peritoneal dissemination and the depth of tumor invasion in gastric cancers. Methods: Initially, the DNA copy number aberrations (DCNAs) were analyzed by array-based comparative genomic hybridization (aCGH) in 83 gastric adenocarcinomas as a training-sample set. Next, two independent analytical methods were applied to the aCGH data to identify the BAC clones with DNA copy number aberrations that were linked with the disease states. One of the methods, a decision-tree model classifier, identified 6, 4, 4, 4, and 7 clones for estimating lymph node metastasis, liver metastasis, peritoneal dissemination, depth of tumor invasion, and histological type, respectively. In the other method, a clone-by-clone comparison of the frequency of the DNA copy number aberrations selected 26 clones to estimate the disease states. Results: By spotting these 50 clones together with 26 frequently or rarely involved clones and 62 reference clones, a mini-array was made to estimate the above parameters, and the diagnostic performance of the mini-array was evaluated for an independent set of 30 gastric cancers (blinded – sample set). In comparison to the clinicopathological features, the overall accuracy was 66.7% for node metastasis, 86.7% for liver metastasis, 86.7% for peritoneal dissemination, and 96.7% for depth of tumor invasion. The intratumoral heterogeneity barely affected the diagnostic performance of the mini-array. Conclusion: These results suggest that the mini-array makes it possible to determine an optimal treatment for each of the patients with gastric adenocarcinoma.


    • 1 December 2007
      • Vol. 54  (80) , 2221-7

    Study on the colonoscopic features of GVHD enteritis that developed after hematopoietic stem cell transplantation.

    by Katsunori Harada, Shingo Higaki, Kazuo Hashimoto, Shinichi Hashimoto, Atsunori Oga, Toshikazu Gondo, Isao Sakaida

    Graft-versus-host disease (GVHD) enteritis is a frequent gastrointestinal complication following hematopoietic stem cell transplantation (HSCT). The diagnosis of GVHD enteritis was made if apoptotic bodies in crypt epithelium were observed in a biopsy specimen(s). However, there is no standardized protocol as to what colonoscopic findings to use as a guide, and from which segment of the colon and how many biopsy specimens should be obtained. Our aim was to develop a colonoscopic protocol for detection of GVHD enteritis. This retrospective study included 19 patients who had refractory watery diarrhea beyond day 20 after HSCT and underwent colonoscopic examination. Four to nine colonoscopic biopsy specimens were obtained from various regions of the colon in each patient. Fifteen of the 19 patients were diagnosed with GVHD enteritis. In the 15 patients with GVHD enteritis, colonoscopy revealed non-specific findings such as edema, redness, and erosions. Apoptotic bodies were found in one biopsy specimen in 7 patients, 2 biopsy specimens in 5 patients, and 3 or more biopsy specimens in 3 patients. Apoptotic bodies were found in the distal colon (descending colon or sigmoid colon or rectum) in 8 patients, and in the proximal to transverse colon in the remaining 7 patients. Apoptotic bodies were most frequently detected in colonoscopic biopsy specimens of erosions and aphthous lesions. When patients who have undergone HSCT develop refractory diarrhea, many biopsy specimens from the entire colon should be obtained on colonoscopic examination for histopathologic detection of GVHD enteritis.


    • 1 May 2007
      • Vol. 29  (5) , 355-9

    [Clinicopathologic significance of chromosomal DNA sequence copy number aberrations in patients with colorectal carcinoma].

    by Xiu-Ping Liu, Shigeto Kawauchi, Atsunori Oga, Kohsuke Sasaki

    To analyze the correlation of DNA sequence copy number aberrations (DSCNAs)with clinicopathologic parameters in patients with colorectal cancer(CRC). Comparative genomic hybridization (CGH) method was used in analysis of 73 cases with CRC. Statistical analysis was performed using Stat View statistical software package(5.0). Loss of 8pl2-pter and gain of 8q23-qter were linked to nodal metastasis, while loss of 18q12-qter and gain of 8q23-qter were associated with distant organ metastasis at diagnosis and (or) recurrence after surgery. Moreover, losses of 8pl2-pter and 18q12-qter and gain of 8q23-qter were associated significantly with unfavorable prognosis. Multivariate analysis revealed that loss of 18q12-qter was an independent prognostic marker. Our findings indicate that genetic aberrations detected by CGH may predict outcome in patients with CRC, and may provide useful information for clinical treatment. Comparative genomic hybridization;